{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:58:32Z","timestamp":1793048312268,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["20-6\/2009(i)EU-IV"],"award-info":[{"award-number":["20-6\/2009(i)EU-IV"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["10-2(5)\/2007(i)-EU-II"],"award-info":[{"award-number":["10-2(5)\/2007(i)-EU-II"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2013-20840"],"award-info":[{"award-number":["2013-20840"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome DBT India Alliance","award":["IA\/S\/11\/2500267"],"award-info":[{"award-number":["IA\/S\/11\/2500267"]}]},{"name":"Wellcome DBT India Alliance","award":["IA\/S\/15\/1\/501842"],"award-info":[{"award-number":["IA\/S\/15\/1\/501842"]}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/COE\/34\/SP13432\/2015"],"award-info":[{"award-number":["BT\/COE\/34\/SP13432\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR8742\/AGR\/36\/773\/2013"],"award-info":[{"award-number":["BT\/PR8742\/AGR\/36\/773\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177227","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T18:04:25Z","timestamp":1494871465000},"page":"e0177227","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2"],"prefix":"10.1371","volume":"12","author":[{"given":"Sreeja","family":"Karathedath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathi M.","family":"Rajamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Mohammed","family":"Musheer Aalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Varatharajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Krishnamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji Ramachandran","family":"Velayudhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-439X","authenticated-orcid":true,"given":"Poonkuzhali","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/annonc\/mdp309","article-title":"Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006\u20132010","volume":"21","author":"D Pulte","year":"2010","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2016-01-635060","article-title":"How I treat acute myeloid leukemia presenting with preexisting comorbidities","volume":"128","author":"Y Ofran","year":"2016","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1200\/JCO.2011.35.7525","article-title":"Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment","volume":"29","author":"RB Walter","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"T Lapidot","year":"1994","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"M Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref6","first-page":"81","article-title":"Cell cycle regulation of hematopoietic stem cells","volume":"11","author":"Y Furukawa","year":"1998","journal-title":"Hum Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2013-04-491944","article-title":"Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling","volume":"122","author":"PS Hole","year":"2013","journal-title":"Blood"},{"key":"ref8","article-title":"Palbociclib treatment of FLT3-ITD+ AML cells uncovers a kinase-dependent transcriptional regulation of FLT3 and PIM1 by CDK6","author":"IZ Uras","year":"2016","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","article-title":"BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells","volume":"12","author":"ED Lagadinou","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e71266","DOI":"10.1371\/journal.pone.0071266","article-title":"The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions","volume":"8","author":"J Bhullar","year":"2013","journal-title":"PloS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0076-6879(05)01019-0","article-title":"Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets","volume":"401","author":"DM Townsend","year":"2005","journal-title":"Methods Enzymol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1016\/S0021-9258(18)99004-6","article-title":"The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity","volume":"266","author":"TH Rushmore","year":"1991","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.7314\/APJCP.2013.14.9.5231","article-title":"Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer","volume":"14","author":"X-F Hu","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/carcin\/bgt108","article-title":"Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402\/ADM cells to doxorubicin via inhibiting PI3K\/Akt\/Nrf2 pathway","volume":"34","author":"A-M Gao","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-07-5003","article-title":"Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth","volume":"68","author":"T Ohta","year":"2008","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-12-66","article-title":"Methylation of the KEAP1 gene promoter region in human colorectal cancer","volume":"12","author":"N Hanada","year":"2012","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1158\/0008-5472.CAN-14-1439","article-title":"Oncogenic KRAS confers chemoresistance by upregulating NRF2","volume":"74","author":"S Tao","year":"2014","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.freeradbiomed.2006.06.010","article-title":"Peroxynitrite induces HO-1 expression via PI3K\/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells","volume":"41","author":"M-H Li","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cancers3021605","article-title":"The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells","volume":"3","author":"SA Rushworth","year":"2011","journal-title":"Cancers"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1755-8794-3-37","article-title":"The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel","volume":"3","author":"Q Liu","year":"2010","journal-title":"BMC Med Genomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2014.11.003","article-title":"Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2","volume":"78","author":"A Olayanju","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.freeradbiomed.2011.03.008","article-title":"Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2\/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs","volume":"50","author":"X Tang","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1038\/cddis.2013.467","article-title":"Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors","volume":"4","author":"Y Liu","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1038\/onc.2012.493","article-title":"Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity","volume":"32","author":"A Arlt","year":"2013","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2015.12.008","article-title":"Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells","volume":"292","author":"H Peng","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.1014275108","article-title":"Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism","volume":"108","author":"D Ren","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nature16139","article-title":"Replication stress activates DNA repair synthesis in mitosis","volume":"528","author":"S Minocherhomji","year":"2015","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ncb3341","article-title":"Glutathione biosynthesis is a metabolic vulnerability in PI3K\/Akt-driven breast cancer","volume":"18","author":"EC Lien","year":"2016","journal-title":"Nat Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e2093","DOI":"10.1038\/cddis.2016.3","article-title":"Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53-SIRT1 axis","volume":"7","author":"DS Yoon","year":"2016","journal-title":"Cell Death Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"X-J Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jso.21520","article-title":"Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer","volume":"101","author":"T Takahashi","year":"2010","journal-title":"J Surg Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1182\/blood-2012-04-422121","article-title":"The high Nrf2 expression in human acute myeloid leukemia is driven by NF-\u03baB and underlies its chemo-resistance","volume":"120","author":"SA Rushworth","year":"2012","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Y Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"26882","DOI":"10.1074\/jbc.M114.567685","article-title":"Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses","volume":"289","author":"C Biswas","year":"2014","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-4598-10-37","article-title":"Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy","volume":"10","author":"A Lister","year":"2011","journal-title":"Mol Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1038\/cddis.2014.149","article-title":"Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation","volume":"5","author":"KA Kang","year":"2014","journal-title":"Cell Death Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15430\/JCP.2014.19.2.111","article-title":"Targeting Nrf2 Signaling to Combat Chemoresistance","volume":"19","author":"JH No","year":"2014","journal-title":"J Cancer Prev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T04:10:06Z","timestamp":1719202206000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177227"}},"subtitle":[],"editor":[{"given":"Yoshiaki","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177227","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}